Hudson Bay Capital Management LP is 10% Owner at Akers Biosciences, Inc. (AKER). They have made 12 open-market trades across 9 companies since 2013, most recently 2023-09-12.
CIK 0001393825
4 open-market purchases totalling $4.8M since 2013, against 8 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 86% | 57% |
| Avg Move | -7.4% | -3.9% | -2.2% |
| Scored | 8 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRCA | SELL | 2023-04-25 | 2023-04-27 | $10.31 | $4.7M | +0.4% | +1.8% | +4.1% |
| MPAC | BUY | 2022-10-05 | 2022-11-28 | $10.32 | $132K | +1.3% | -15.8% | N/A |
| ZGYH | SELL | 2021-10-22 | 2021-10-26 | $10.98 | $2.2M | +0.1% | N/A | N/A |
| AMCI | SELL | 2020-11-27 | 2020-12-01 | $11.27 | $1.1M | +0.8% | -1.0% | -1.0% |
| TDAC | SELL | 2020-07-10 | 2020-07-15 | $10.88 | $7.7M | -0.8% | -1.9% | +0.0% |
| AMCI | BUY | 2020-03-25 | 2020-03-27 | $10.15 | $3.9M | +0.8% | -1.0% | -1.0% |
| AKER | SELL | 2020-02-25 | 2020-02-27 | $2.81 | $80K | -8.0% | -21.1% | +27.4% |
| AKER | BUY | 2019-12-09 | 2020-01-07 | $3.02 | $695K | +3.0% | +7.8% | +40.0% |
| LOACU | SELL | 2018-09-11 | 2018-09-13 | $10.20 | $408K | +0.3% | -0.1% | -0.9% |
| HCHC | SELL | 2015-10-15 | 2015-10-19 | $7.50 | $3.9M | -26.1% | -2.7% | -28.8% |
| HCHC | SELL | 2015-10-09 | 2015-10-13 | $7.85 | $687K | -26.1% | -2.7% | -16.0% |
| TWFH | BUY | 2013-05-09 | 2013-05-10 | $0.19 | $65K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| HCHC |
| 254,372 |
| $936K |
| TWFH | 693,558 | — |
| Total | $42.1M |
Shares reported on the most recent Form 4, priced at the 2023-04-27 close. 1 holding could not be priced and is excluded from the total.